Kaiser Permanente Riverside Medical Center
Riverside, California, 92505, United States
NCT Number: NCT03569410
This study is a prospective open label clinical trial comparing serum albumin levels and total protein intake in the peritoneal dialysis patient population. A total of 60 patients were enrolled, 16 chose to be in the natural food group and 44 in the supplement group. 4 were lost to follow-up in the supplement group leading to an n of 40. Both groups were educated by dietitians on how to increase their protein intake to a goal of 1.4g/kg/day. The groups were followed for 3 months with protein intake calculated according to the patient's food diaries. Patient demographics and characteristics were compared in both groups.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Riverside, California, 92505, United States
This is a prospective open label clinical trial comparing serum albumin levels and total protein intake in the peritoneal dialysis patient population. Two treatment groups were established: a natural food group who was instructed by their dietician in how to reach their goal protein intake through purely increasing the consumption of natural foods rich in protein versus a protein supplement group who was instructed by their dietician in how many protein supplements to consume in addition to their natural food intake in order to reach their goal protein intake. To increase compliance, patients were allowed to choose which treatment group they wanted to participate in. Patients, however, were not allowed to change groups during the study.
At the initiation of the study patients were asked to record food diaries so the dietician can calculate their baseline protein intake. Each patient had an assigned dietician who met with the patient monthly. The food diaries were collected during their monthly visits. Patients were also randomly called and asked to give their food intake during the last 24 hours in order to minimize recall bias. Each month the participant's dietician calculated their protein intake deficit and educated the patient on how to increase their protein intake to reach their goal of 1.4g/kg/day. The recommended protein intake for peritoneal dialysis patients is between 1.2 to 1.5 g/kg/day. Therefore, a goal of 1.4g/kg/day was set, which is at the higher end of the goal range in order to ensure an adequately high protein intake.
The patient's serum albumin levels, phosphate levels, kt/v, and total protein intake were recorded at baseline, month 1 (M1), month 2 (M2), and month 3 (M3). Furthermore, all major comorbidities in each patient were recorded and compared. Data was extracted from the electronical medical record system and entered into a password protected file. This data was then analyzed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients had to eat 1.4g/kg/day of natural protein.
Patients ate enough protein supplements in addition to their regular diet to reach eat 1.4g/kg/day of protein intake.
Time frame: After three months of intervention.
serum levels of albumin
Time frame: At Month 0, 1, 2, and 3
measured monthly
Time frame: At Month 0, 1, 2, and 3
Via food diaries the total protein intake was calculated
Time frame: At Month 0, 1, 2, and 3
throughout the study
Kaiser Permanente
Other
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients An Open-label Prospective Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04046263
Blood Protein Disorders, Hematologic Diseases
Aurora, Colorado, United States
View Trial DetailsNCT07000006
Back Pain, Chronic Disease
Isfahan, Iran
View Trial DetailsNCT06787599
Chronic Disease, Disease Attributes
Isfahan, Iran
View Trial DetailsNCT04797195
Chronic Disease, Disease Attributes
Chaiyaphum, Thailand
View Trial Details